REPLIKIN peptides and uses thereof

A peptide sequence, influenza virus technology, applied in the field of peptides with shared structural features, Replikin
CN1849332AInactive Publication Date: 2006-10-18塞缪尔·博戈奇 +1

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
塞缪尔·博戈奇
Publication Date
2006-10-18
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention discloses influenza virus hemagglutinin protein and peptide of malaria antigen of Plasmodium falciparum (Plasmodium falciparum), antibody specific to said peptide, influenza vaccine, malaria vaccine and immunity stimulating patients to produce anti-influenza virus or malaria antibody method of response. The invention also discloses methods for formulating vaccines against influenza viruses. The invention discloses an isolated peptide of Bacillus anthracis (Bacillus anthracis) anthrax toxin lethal factor protein pX01-107, an antibody specific to the peptide and an antibody that stimulates patients to produce anti-Bacillus anthracis anthrax toxin lethal factor protein pX01-107 method of the immune response. The present invention also discloses isolated peptides of the smallpox virus surface antigen S precursor protein, antibodies specific to said peptides and methods of stimulating an immune response in a patient to produce antibodies against the smallpox virus surface antigen S precursor protein.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-references to other applications

[0002] This application is a continuation-in-part of application numbers US 09 / 984,056 and US 09 / 984,057, filed concurrently on October 26, 2001, which claim provisional application 60 / 303,396, filed on July 9, 2001, and 2001 Priority to provisional application 60 / 278,761, filed March 27, the subject matter of which is incorporated herein by reference. field of invention

[0003] The present invention relates to the identification and use of Replikins, a class of peptides with shared structural features. In particular, the invention relates to Replikins that have been identified in influenza viruses and their use in the design of influenza virus vaccines. The invention also relates to Replikins which have been identified in Bacillus anthracis and Small Pox Virus (Variola). Background of the invention

[0004] Influenza is an acute respiratory disease of global importance. Despite attempts by countries and international organ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More